GLSI
Price
$8.93
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
120.05M
43 days until earnings call
MBIO
Price
$1.02
Change
-$0.01 (-0.97%)
Updated
Jun 27 closing price
Capitalization
4.47M
Interact to see
Advertisement

GLSI vs MBIO

Header iconGLSI vs MBIO Comparison
Open Charts GLSI vs MBIOBanner chart's image
Greenwich LifeSciences
Price$8.93
Change-$0.00 (-0.00%)
Volume$337
Capitalization120.05M
Mustang Bio
Price$1.02
Change-$0.01 (-0.97%)
Volume$172.48K
Capitalization4.47M
GLSI vs MBIO Comparison Chart in %
Loading...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLSI vs. MBIO commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLSI is a Hold and MBIO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (GLSI: $8.93 vs. MBIO: $1.02)
Brand notoriety: GLSI and MBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLSI: 1% vs. MBIO: 32%
Market capitalization -- GLSI: $120.05M vs. MBIO: $4.47M
GLSI [@Biotechnology] is valued at $120.05M. MBIO’s [@Biotechnology] market capitalization is $4.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLSI’s FA Score shows that 0 FA rating(s) are green whileMBIO’s FA Score has 0 green FA rating(s).

  • GLSI’s FA Score: 0 green, 5 red.
  • MBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, both GLSI and MBIO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLSI’s TA Score shows that 2 TA indicator(s) are bullish while MBIO’s TA Score has 3 bullish TA indicator(s).

  • GLSI’s TA Score: 2 bullish, 6 bearish.
  • MBIO’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, MBIO is a better buy in the short-term than GLSI.

Price Growth

GLSI (@Biotechnology) experienced а +0.11% price change this week, while MBIO (@Biotechnology) price change was -2.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

GLSI is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLSI($120M) has a higher market cap than MBIO($4.47M). GLSI YTD gains are higher at: -20.481 vs. MBIO (-88.475). MBIO has higher annual earnings (EBITDA): -10.6M vs. GLSI (-16.75M). MBIO has more cash in the bank: 14.2M vs. GLSI (2.75M). GLSI (0) and MBIO (0) have equivalent revenues.
GLSIMBIOGLSI / MBIO
Capitalization120M4.47M2,688%
EBITDA-16.75M-10.6M158%
Gain YTD-20.481-88.47523%
P/E RatioN/AN/A-
Revenue00-
Total Cash2.75M14.2M19%
Total DebtN/A0-
FUNDAMENTALS RATINGS
MBIO: Fundamental Ratings
MBIO
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLSIMBIO
RSI
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
76%
Aroon
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD6.001.49
+33.04%
Auddia Inc
TXRH187.742.71
+1.46%
Texas Roadhouse
RSI14.710.20
+1.38%
Rush Street Interactive
PJT166.410.05
+0.03%
PJT Partners
RILY2.93-0.06
-2.01%
B. Riley Financial

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with ABOS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
N/A
ABOS - GLSI
48%
Loosely correlated
-7.44%
DNLI - GLSI
45%
Loosely correlated
-2.69%
IMNM - GLSI
44%
Loosely correlated
-0.23%
CLDX - GLSI
43%
Loosely correlated
-4.16%
CRSP - GLSI
42%
Loosely correlated
N/A
More

MBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MBIO has been loosely correlated with SLRX. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if MBIO jumps, then SLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBIO
1D Price
Change %
MBIO100%
-0.97%
SLRX - MBIO
63%
Loosely correlated
-0.01%
IPHYF - MBIO
42%
Loosely correlated
N/A
SCNI - MBIO
37%
Loosely correlated
-7.69%
MIRM - MBIO
34%
Loosely correlated
+1.05%
GLSI - MBIO
32%
Poorly correlated
N/A
More